WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

Investors who purchased GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), are encouraged to contact the Schall Law Firm before August 3, 2026. The Company made false and misleading statements to the market. GeneDx reported its Q1 2026 financial results on May 4, 2026. The Company revealed a drop in adjusted gross margin, lowered its projected earnings, and announced a $31.3 million impairment related to Fabric Genomics. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about GeneDx, investors suffered damages.